Q4 2024 Earnings Call Transcript March 20, 2025 Monte Rosa Therapeutics, Inc. beats earnings expectations. Reported EPS is $0 ...

Dr. Debu Tripathy explains how ctDNA is used to in breast cancer detection and how it can also indicate the presence of MRD.

Previously reported MRD negative CR in 2 of 3 relapsed/refractory AML patients enrolled in first dose level and schedule of Phase 1 clinical ...

This advertisement has not loaded yet, but your article continues below. The diss track reached its peak of cultural prominence at the Super Bowl, when Kendrick Lamar performed Not Like Us, his ...

Treatment Blood Test Offers New Hope for Personalized Cancer Therapy DecisionsA new Yale study has found evidence to support ...

A new Yale study has found evidence to support the value of a tool that measures the presence of cancer -derived molecules in ...

Darzalex and Revlimid maintenance resulted in superior outcomes versus Revlimid alone following autologous stem cell ...

A multivariate analysis confirmed the independent prognostic significance of both landmark and longitudinal MRD.

In the continuing evolution of personalized medicine, a new Yale study has found evidence to support the value of a tool that ...

In the continuing evolution of personalized medicine, a new Yale study has found evidence to support the value of a tool that ...

In the continuing evolution of personalized medicine, a new Yale study has found evidence to support the value of a tool that measures the presence of ...

Why have BMS investors been anything but positive about acquiring 2seventy? The answer stems from uncertainty over how ...